日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Activation of SIK1 by phanginin A regulates skeletal muscle glucose uptake by phosphorylating HADC4/5/7 and enhancing GLUT4 expression and translocation.

phanginin A 激活 SIK1，通过磷酸化 HADC4/5/7 和增强 GLUT4 的表达和转位来调节骨骼肌葡萄糖的摄取

期刊:Natural Products and Bioprospecting
影响因子:4.9
doi:10.1007/s13659-025-00504-z
Shi Yu, Wu Xing-de, Liu Yanli, Shen Yu, Qu Hui, Zhao Qin-Shi, Leng Ying, Huang Suling
骨科研究
磷酸化
发表日期：2025
文献求助 收藏

Application of NRS2002 in Preoperative Nutritional Screening for Patients with Liver Cancer

NRS2002在肝癌患者术前营养筛查中的应用

期刊:Journal of Oncology
影响因子:
doi:10.1155/2021/8943353
Huang, Suling; Wang, Shijie; Xie, Yuankang; He, Xiao; Yi, Xiuying; Zhang, Jianhong; Deng, Zuomei; Yin, Ling
肿瘤
肝癌
肿瘤免疫
RS2
发表日期：2021
文献求助 收藏

Interfering MSN-NONO complex-activated CREB signaling serves as a therapeutic strategy for triple-negative breast cancer

干扰MSN-NONO复合物激活的CREB信号作为三阴性乳腺癌的治疗策略

期刊:Science Advances
影响因子:11.7
doi:10.1126/sciadv.aaw9960
Yuanyuan Qin, Weilong Chen, Guojuan Jiang, Lei Zhou, Xiaoli Yang, Hongqi Li, Xueyan He, Han-Lin Wang, Yu-Bo Zhou, Shenglin Huang, Suling Liu
信号转导
肿瘤
乳腺癌
FCM
IF
IHC-P
WB
发表日期：2020
文献求助 收藏

Linderane Suppresses Hepatic Gluconeogenesis by Inhibiting the cAMP/PKA/CREB Pathway Through Indirect Activation of PDE 3 via ERK/STAT3

林德兰通过ERK/STAT3间接激活PDE3，从而抑制cAMP/PKA/CREB通路，进而抑制肝糖异生。

期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2018.00476
Xie, Wei; Ye, Yangliang; Feng, Ying; Xu, Tifei; Huang, Suling; Shen, Jianhua; Leng, Ying
PKA
JAK/STAT
信号转导
MAPK/ERK
STAT3
CREB
GPCR/Calcium/cAMP
发表日期：2018
文献求助 收藏